ChemicalBook > CAS DataBase List > doxorubicin(6-maleimidocaproyl)hydrazone

doxorubicin(6-maleimidocaproyl)hydrazone

Product Name
doxorubicin(6-maleimidocaproyl)hydrazone
CAS No.
151038-96-9
Chemical Name
doxorubicin(6-maleimidocaproyl)hydrazone
Synonyms
DOXO-EMCH;INNO-206;MC-DOXHZN;Aldoxorubici;Doxorubicin-EMCH;MC DOXHZN,MCDOXHZN;INNO-206 (Aldoxorubicin);Doxorubicin-hydrazone-caproyl-maleimide;doxorubicin(6-maleimidocaproyl)hydrazone;DOXO-EMCH; DOXORUBICIN-EMCH; INNO206;INNO 206;ALDOXORUBICIN
CBNumber
CB51374839
Molecular Formula
C37H42N4O13
Formula Weight
750.74838
MOL File
151038-96-9.mol
More
Less

doxorubicin(6-maleimidocaproyl)hydrazone Property

Density 
1.60
solubility 
Soluble in DMSO
pka
7.38±0.60(Predicted)
More
Less

Safety

Safety Statements 
23-24/25
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

ApexBio Technology
Product number
A3372
Product name
DOXO-EMCH
Packaging
2mg
Price
$113
Updated
2021/12/16
ApexBio Technology
Product number
A3372
Product name
DOXO-EMCH
Packaging
5mg
Price
$188
Updated
2021/12/16
ApexBio Technology
Product number
A3372
Product name
DOXO-EMCH
Packaging
10mg
Price
$255
Updated
2021/12/16
American Custom Chemicals Corporation
Product number
API0005221
Product name
INNO-206
Purity
95.00%
Packaging
5MG
Price
$922.3
Updated
2021/12/16
ApexBio Technology
Product number
A3372
Product name
DOXO-EMCH
Packaging
50mg
Price
$960
Updated
2021/12/16
More
Less

doxorubicin(6-maleimidocaproyl)hydrazone Chemical Properties,Usage,Production

Uses

Doxorubicin-hydrazone-caproyl-maleimide is an albumin-binding prodrug of doxorubicin and a promising clinical candidate for the treatment of a broad range of solid tumors

Biological Activity

the (6-maleimidocaproyl) hydrazone derivative of doxorubicin (inno-206), formerly known as doxo-emch, is a prodrug of the anticancer agent doxorubicin which selectively binds to the cys34 of circulating albumin and accumulates in solid tumors due to passive targeting[1]. inno-206 shows significantly superior antitumor efficacy over free doxorubicin in a spectrum of preclinical tumor models [2].

in vivo

in a murine renal cell carcinoma model and in breast carcinoma xenograft models, inno-206 has shown superior activity over doxorubicin. inno-206 has shown more potent antitumor efficacy than free doxorubicin in the tumor models and is thus a promising clinical candidate for treating a broad range of solid tumors [2].

References

[1]. kratz f. doxo-emch (inno-206): the first albumin-binding prodrug of doxorubicin to enter

doxorubicin(6-maleimidocaproyl)hydrazone Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

doxorubicin(6-maleimidocaproyl)hydrazone Suppliers

AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Fax
+1 (866) 333-9607
Email
info@adooq.com
Country
United States
ProdList
2784
Advantage
58
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4662
Advantage
60
TargetMol Chemicals Inc.
Tel
+1-781-999-5354 +1-00000000000
Email
marketing@targetmol.com
Country
United States
ProdList
19892
Advantage
58
AB PharmaTech,LLC
Tel
323-480-4688
Fax
323-480-4688
Country
United States
ProdList
989
Advantage
55
More
Less

View Lastest Price from doxorubicin(6-maleimidocaproyl)hydrazone manufacturers

Career Henan Chemical Co
Product
DOXO-EMCH 151038-96-9
Price
US $1.00/g
Min. Order
1g
Purity
95-99%
Supply Ability
1ton
Release date
2020-01-10
Career Henan Chemical Co
Product
doxorubicin(6-maleimidocaproyl)hydrazone 151038-96-9
Price
US $1.00/g
Min. Order
1g
Purity
99%
Supply Ability
200kg
Release date
2020-01-10

151038-96-9, doxorubicin(6-maleimidocaproyl)hydrazoneRelated Search:


  • doxorubicin(6-maleimidocaproyl)hydrazone
  • (E)-N'-(1-((2R,4R)-4-((2S,4R,5R,6R)-4-aMino-5-hydroxy-6-Methyltetrahydro-2H-pyran-2-yloxy)-2,5,12-trihydroxy-7-Methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)-2-hydroxyethylidene)-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanehydrazide
  • INNO-206
  • INNO-206 (Aldoxorubicin)
  • DOXO-EMCH
  • Doxorubicin-EMCH
  • N'-[(1E)-1-{4-[(3-Amino-2,3,6-trideoxyhexopyranosyl)oxy]-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-2-tetracenyl}-2-hydroxyethylidene]-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexane hydrazide
  • MC-DOXHZN
  • DOXO-EMCH; DOXORUBICIN-EMCH; INNO206;INNO 206;ALDOXORUBICIN
  • 1H-Pyrrole-1-hexanoic acid, 2,5-dihydro-2,5-dioxo-, 2-[1-[(2S,4S)-4-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]-2-hydroxyethylidene]hydrazide
  • Doxorubicin-hydrazone-caproyl-maleimide
  • 1H-Pyrrole-1-hexanoicacid, 2,5-dihydro-2,5-dioxo-, [1-[(2S,4S)-4-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]-2-hydroxyethylidene]hydrazide
  • Aldoxorubici
  • MC DOXHZN,MCDOXHZN
  • 151038-96-9
  • C37H42N4O13